These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15963075)

  • 1. Review article: the changing epidemiology of hepatocellular carcinoma in Canada.
    Dyer Z; Peltekian K; van Zanten SV
    Aliment Pharmacol Ther; 2005 Jul; 22(1):17-22. PubMed ID: 15963075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatocellular carcinoma in Canada, 1995: analysis of death certificates.
    ElSaadany S; Giulivi A
    Chronic Dis Can; 2006; 27(3):125-9. PubMed ID: 17306064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
    Hwang JC; Weng SF; Weng RH
    Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of primary hepatic malignancies in U.S. children.
    Darbari A; Sabin KM; Shapiro CN; Schwarz KB
    Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.
    Pocobelli G; Cook LS; Brant R; Lee SS
    Liver Int; 2008 Nov; 28(9):1272-9. PubMed ID: 18384523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001.
    Shibuya K; Yano E
    Int J Epidemiol; 2005 Apr; 34(2):397-402. PubMed ID: 15561746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality from hepatocellular and biliary cancers: changing epidemiological trends.
    Nair S; Shiv Kumar K; Thuluvath PJ
    Am J Gastroenterol; 2002 Jan; 97(1):167-71. PubMed ID: 11808943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of diabetes mellitus in a rural Greek population.
    Melidonis AM; Tournis SM; Kompoti MK; Lentzas IL; Roussou VR; Iraklianou SL; Michail IM; Mariolis AM
    Rural Remote Health; 2006; 6(1):534. PubMed ID: 16579675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of increased mortality from hepatocellular carcinoma in high incidence country: Taiwan experience.
    Jan CF; Chen CJ; Chen HH
    J Gastroenterol Hepatol; 2005 Apr; 20(4):521-6. PubMed ID: 15836699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Ohki T; Tateishi R; Sato T; Masuzaki R; Imamura J; Goto T; Yamashiki N; Yoshida H; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):459-64. PubMed ID: 18387499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.
    Kulkarni K; Barcak E; El-Serag H; Goodgame R
    Aliment Pharmacol Ther; 2004 Aug; 20(4):445-50. PubMed ID: 15298639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.
    Amin J; O'Connell D; Bartlett M; Tracey E; Kaldor J; Law M; Dore G
    Aust N Z J Public Health; 2007 Oct; 31(5):475-82. PubMed ID: 17931297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center.
    Abdel-Wahab M; El-Ghawalby N; Mostafa M; Sultan A; El-Sadany M; Fathy O; Salah T; Ezzat F
    Hepatogastroenterology; 2007; 54(73):157-62. PubMed ID: 17419252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.
    Kawamura Y; Ikeda K; Arase Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1739-46. PubMed ID: 18713301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of diabetes mellitus in Canada.
    Tan MH; MacLean DR
    Clin Invest Med; 1995 Aug; 18(4):240-6. PubMed ID: 8549008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.